CSPC Pharmaceutical boosts share award scheme with HK$28m market purchase

CSPC Pharmaceutical Group Limited announced an on-market purchase of 3,000,000 shares on October 13, 2025. These shares will be held in trust for selected participants under its Share Award Scheme and represent approximately 0.026% of the company's existing total shares in issue.

The total consideration for this acquisition amounted to approximately HK$27,975,000, with an average price per share of approximately HK$9.3251. Following this transaction, the total balance of shares held by the Trustee for the scheme now stands at 103,000,000 shares.

The Share Award Scheme, initially adopted on August 20, 2018, and amended on May 21, 2024, allows the board to determine the number of shares awarded and future on-market purchases at its discretion. This latest purchase underscores CSPC Pharmaceutical's ongoing strategy to align employee interests with shareholder value.